Thus, IFNα is able to induce the expression of other pathogenic cytokines in SLE, such as BLyS and IL-17, acting in a pathological axis that perpetuates the inflammation and disease progression (2, 16, 17). This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.